Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Cash (2016 - 2025)

Historic Change in Cash for Sunshine Biopharma (SBFM) over the last 14 years, with Q3 2025 value amounting to -$770560.0.

  • Sunshine Biopharma's Change in Cash fell 95020.99% to -$770560.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.4 million, marking a year-over-year increase of 6457.11%. This contributed to the annual value of -$5.6 million for FY2024, which is 737.89% up from last year.
  • Per Sunshine Biopharma's latest filing, its Change in Cash stood at -$770560.0 for Q3 2025, which was down 95020.99% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Change in Cash ranged from a high of $28.5 million in Q2 2022 and a low of -$19.0 million during Q4 2022
  • Its 5-year average for Change in Cash is $454076.6, with a median of -$335777.0 in 2021.
  • Its Change in Cash has fluctuated over the past 5 years, first skyrocketed by 4195955.08% in 2022, then tumbled by 2527024.69% in 2024.
  • Over the past 5 years, Sunshine Biopharma's Change in Cash (Quarter) stood at -$335777.0 in 2021, then crashed by 5547.28% to -$19.0 million in 2022, then soared by 84.23% to -$3.0 million in 2023, then soared by 36.95% to -$1.9 million in 2024, then surged by 59.12% to -$770560.0 in 2025.
  • Its Change in Cash stands at -$770560.0 for Q3 2025, versus $1.8 million for Q2 2025 and -$1.6 million for Q1 2025.